Health Care • Medical/Dental Instruments
$9.75 ▲ +0.41
(+4.39%)
MKT CAP: $515.5M • VOL: 522.7K
52W L $5 52W H $11
ROARABLE / RQD
D- • 38/100
PIOTROSKI
5 / 9
SENS // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $35.3M | $22.5M | $22.4M |
| YoY Revenue Growth % | +56.9% | +0.4% | — |
| Gross Profit | $15.8M | $533.0K | — |
| Gross Margin % | 44.7% | 2.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$68.3M | -$74.8M | -$75.6M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$69.1M | -$78.6M | -$60.4M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$59.1M | -$60.5M | -$70.2M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | -$59.1M | -$60.5M | -$70.2M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $40.2M | $74.6M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $61.0M | -$16.6M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR SENS.